164 related articles for article (PubMed ID: 36069388)
1. Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations.
Thompson JL; Sinco BR; McCaffrey RL; Chang AE; Sabel MS; Dossett LA; Hughes TM; Jeruss JS
J Surg Oncol; 2023 Jan; 127(1):18-27. PubMed ID: 36069388
[TBL] [Abstract][Full Text] [Related]
2. Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
Madan V; Mamounas EP
Clin Breast Cancer; 2023 Feb; 23(2):231-236. PubMed ID: 36575101
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Cancer and Role of Sentinel Lymph Node Biopsy in BRCA Mutation Carriers Undergoing Prophylactic Mastectomies.
Fat SC; Weed C; Samaha Y; Chung A; Boyle MK; Giuliano A; Ray E; Amersi F
Am Surg; 2023 Oct; 89(10):4066-4071. PubMed ID: 37184070
[TBL] [Abstract][Full Text] [Related]
4. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
Wong SM; Ferroum A; Apostolova C; Alhassan B; Prakash I; Basik M; Boileau JF; Meterissian S; Aleynikova O; Wong N; Foulkes WD
Ann Surg Oncol; 2022 Oct; 29(11):6660-6668. PubMed ID: 35616744
[TBL] [Abstract][Full Text] [Related]
6. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
7. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
[TBL] [Abstract][Full Text] [Related]
8. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
[TBL] [Abstract][Full Text] [Related]
9. Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy.
Czyszczon IA; Roland L; Sahoo S
J Surg Oncol; 2012 Jun; 105(7):650-4. PubMed ID: 22213101
[TBL] [Abstract][Full Text] [Related]
10. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy.
Laronga C; Lee MC; McGuire KP; Meade T; Carter WB; Hoover S; Cox CE
J Am Coll Surg; 2009 Dec; 209(6):746-52; quiz 800-1. PubMed ID: 19959044
[TBL] [Abstract][Full Text] [Related]
11. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
Freitas V; Crystal P; Kulkarni SR; Ghai S; Bukhanov K; Escallon J; Scaranelo AM
Cancer Med; 2016 Jun; 5(6):1031-6. PubMed ID: 26992816
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
13. Selective use of sentinel lymph node surgery during prophylactic mastectomy.
Boughey JC; Khakpour N; Meric-Bernstam F; Ross MI; Kuerer HM; Singletary SE; Babiera GV; Arun B; Hunt KK; Bedrosian I
Cancer; 2006 Oct; 107(7):1440-7. PubMed ID: 16955504
[TBL] [Abstract][Full Text] [Related]
14. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.
Dupont EL; Kuhn MA; McCann C; Salud C; Spanton JL; Cox CE
Am J Surg; 2000 Oct; 180(4):274-7. PubMed ID: 11113434
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?
Bunting PW; Cyr AE; Gao F; Margenthaler JA
J Surg Oncol; 2014 Jun; 109(8):747-50. PubMed ID: 24535940
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
18. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
19. Selective Use of Sentinel Lymph Node Surgery in Patients Undergoing Prophylactic Mastectomy Using Intraoperative Pathology.
Murphy BL; Glasgow AE; Keeney GL; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):3032-3037. PubMed ID: 28766201
[TBL] [Abstract][Full Text] [Related]
20. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]